RSV combination therapy using a fusion- and a polymerase inhibitor results in increased potency and delayed development of resistance in human lung organoid cultures

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Thuc N.D. Do, Auke E.S. de Zwart, Annelies Riezebos-Brilman, Johan Neyts and Dirk Jochmans

Journal publisher: International Society for Antiviral Research

Published year: 2020